Clinical Trials Directory

Trials / Unknown

UnknownNCT03887039

Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder

Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder: A Cross-Sectional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
78 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Accepted

Summary

Attention-deficit/hyperactivity disorder is the most common childhood neuro-developmental disorder that is characterized by inattention, hyperactivity, and impulsivity. These symptoms last till adulthood in 65% of cases. ADHD has been reported to have a worldwide prevalence of 5.3% and it is more common in boys than in girls (Ghanizadeh 2008; Serra-Negra et al. 2012 and Shooshtari et al. 2013) The symptoms of ADHD are generally treated through behavioral therapy, with or without pharmacological intervention. Medications prescribed are commonly divided into stimulant or non-stimulant drugs. The stimulant medications (such as methylphenidate and amphetamines) have been implicated in adverse oral effects, such as xerostomia and gingival enlargement. The current evidence is controversial regarding the severity and prevalence of dental caries, dental trauma, periodontal diseases, oral habits and tooth wear among patients with ADHD (Chau et al. 2017). In the Arab world, few studies have been published on ADHD. Accordingly, in the Arab society and Egypt there are limited data regarding the oral findings of children with ADHD. Owing to the sparsity of these data, this study will be conducted to evaluate different oral characteristics of Egyptian children with ADHD.

Detailed description

Due to lack of published studies about the oral findings of Egyptian Children with ADHD, this study will be conducted to cover this point.

Conditions

Interventions

TypeNameDescription
OTHERclinical examinationclinical examination for all the oral findings

Timeline

Start date
2019-08-01
Primary completion
2020-06-01
Completion
2020-07-01
First posted
2019-03-22
Last updated
2019-04-16

Source: ClinicalTrials.gov record NCT03887039. Inclusion in this directory is not an endorsement.